Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 633 - 640 of 11616 results
Commerce Department Launches Cross-Sector Consortium on AI Safety — AI: The Washington Report
February 16, 2024| Article| Viewpoint
Client Corner: Meet Co-founder & CEO of Axoft, Paul Le Floch
February 16, 2024| Podcast| Viewpoint
Major Win for California Privacy Protection Agency: Enforcement of Regulations Can Begin Immediately
February 15, 2024| Blog| Viewpoint
Quality System Harmonization Is Here, But with Small Benefit to Device Industry
February 15, 2024| Blog| Viewpoint
USCIS Fee Increases May Have Unintended Consequences
February 15, 2024| News
Hiring Across the 49th Parallel: Traps for the Unwary for Cross-Border US-Canada Hires
February 14, 2024| Blog| Viewpoint
USCIS Online Organizational Accounts and Electronic Filing – the Future has Finally Arrived – Session 1
February 14, 2024| Webinar| Viewpoint
US Judges Are Warning Implementers To Take FRAND Negotiations Seriously, Or Else
February 14, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.